Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: wojcicki Clear Filter

Anne Wojcicki to buy back 23andMe and its data for $305M

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals , the company announced Friday. TTAM will acquire substantially all of 23andMe's assets for $305 million, including its Personal Genome Service and Re

Anne Wojcicki is taking back control of 23andMe

is a news editor covering technology, gaming, and more. He joined The Verge in 2019 after nearly two years at Techmeme. 23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company after it filed for Chapter 11 bankruptcy protection earlier this year. On Friday, 23andMe and TTAM Research Institute, a nonprofit public benefit corporation run by Wojcicki, announced in a press release that TTAM would be buying “substantially all of the Company’s assets” for $305 million. As of l

Anne Wojcicki to buy back 23andMe and its data for $305 million

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals , the company announced Friday. TTAM will acquire substantially all of 23andMe's assets for $305 million, including its Personal Genome Service and Re

23andMe founder Anne Wojcicki will regain control of embattled DNA company after all

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regeneron bought 23andMe for $256 million in a bankruptcy auction, but Wojcicki's nonprofit, TTAM Research Institute, was able to reopen bidding with an "unsolicited offer" of $305 million, The Wall Street Journal reports. A bankruptcy judge agreed to reopen bidding on 23andMe under the condition that Regenero